Three years ago today, our final Phase IIA trial results were released. Since then, we have still not put a jab in an arm for our next trial, despite these outstanding results. I will admit back then I did not think not starting the trial by now was even a remote possibility. Who is to blame?
- Forums
- ASX - By Stock
- PER
- Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations
Ann: Trial Met Primary & Exceeded Secondary Endpoint Expectations, page-223
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.91M |
Open | High | Low | Value | Volume |
7.2¢ | 7.2¢ | 7.1¢ | $7.849K | 109.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 7.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 108899 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.079 |
1 | 10000 | 0.078 |
2 | 20987 | 0.077 |
1 | 33333 | 0.075 |
1 | 100000 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.074 | 45404 | 1 |
0.077 | 120000 | 1 |
0.078 | 78800 | 1 |
0.080 | 150007 | 2 |
0.081 | 821316 | 3 |
Last trade - 15.34pm 28/05/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online